MYRIAD GENETICS, INC.

Lobbying for MYRIAD GENETICS, INC.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $250,000.00 expenses · posted Oct 20, 2025

Lobbying activity 1

Medicare/Medicaid

Congressional oversight of Medicare Advantage and prior authorization issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem